Key Technologies + Innovative Products + Flexible Business Models
Dr. Heidi Wang: Shaping OBI Pharma into a Leading and Thriving Global Biotech Company

OBI Pharma (4174.TWO) held an investor conference this afternoon (12/2), where CEO, Dr. Heidi Wang, unveiled the company’s five-year vision. Leveraging innovative ADC enabling technologies and key products, OBI Pharma has embraced new and flexible business models to work with local and global biotech firms and pharmaceutical companies. Through collaborations and licensing agreements, this strategy seeks to establish sustainable revenue streams and positions OBI Pharma as a promising global biotech company, distinguished by robust R&D capabilities, operational excellence, and a team of great talent.